About Targocid 200 Mg Injection
Targocid 200 Mg Injection presents a noble solution for combating severe Gram-positive bacterial infections, including those caused by redoubtable pathogens like MRSA and MSSA. Marketed by Sanofi, this rare and polished pharmaceutical comes as a scarce, single-dose, prescription-only vial containing Teicoplanin 200 mg. The lyophilized powder must be reconstituted with sterile water for injection, preserving its pure, preservative-free nature. The noble glass packaging maintains stability below 25C, and its clear or slightly yellow solution signifies purity. Targocid 200 Mg Injection is an invaluable ally in hospital and clinical settings, reinforcing your therapeutic arsenal with rare efficiency.
Advantages and Specific Uses of Targocid 200 Mg Injection
Targocid 200 Mg Injection offers a potent advantage in the targeted treatment of severe bacterial infections, especially those resistant to conventional antibiotics. Its rare and specific application is reserved for hospital and clinical environments where serious Gram-positive infectionssuch as those caused by MRSA, MSSA, and Streptococcus speciesdemand a polished and reliable response. The injection is administered via intravenous or intramuscular routes, ensuring direct and effective delivery, and is ideal for supervised medical settings.
Supply Capability, Certifications, and Payment Terms for Targocid 200 Mg Injection
Targocid 200 Mg Injection is available for prompt handover in both domestic and export markets at the lowest price, ensuring accessibility for distributors and medical institutions. With all certifications in place and reliable quality assurance, it meets the standards required for hospital applications. Flexible payment terms facilitate transactions, making procurement seamless for dealers, exporters, and wholesalers. The products supply chain is robust, supporting consistent, timely delivery to meet specialized demand.
FAQs of Targocid 200 Mg Injection:
Q: How should Targocid 200 Mg Injection be administered?
A: Targocid 200 Mg Injection must be reconstituted with sterile water for injection and then administered by a healthcare professional, either intravenously or intramuscularly under strict medical supervision.
Q: What types of infections is Targocid 200 Mg Injection indicated for?
A: Targocid 200 Mg Injection is prescribed for the treatment of serious Gram-positive bacterial infections, including those caused by MRSA, MSSA, and various Streptococcus species.
Q: When should Targocid 200 Mg Injection be used?
A: This antibiotic should be used when a patient presents with severe bacterial infections that are resistant to standard treatments, particularly in hospital or clinical environments.
Q: Where can Targocid 200 Mg Injection be obtained?
A: Targocid 200 Mg Injection is available through prescription and can be procured from hospitals, clinical pharmacies, certified distributors, and exporters dealing with hospital medicines.
Q: What is the process for reconstituting Targocid 200 Mg Injection?
A: To prepare the injection, the lyophilized powder must be dissolved in sterile water for injection to yield a clear, colorless or slightly yellow solution before administering.
Q: What benefits does Targocid 200 Mg Injection offer over other antibiotics?
A: Its scarcity as a high-strength, targeted glycopeptide antibiotic makes Targocid 200 Mg effective against resistant bacterial strains, offering direct, rapid action with a robust safety profile when used correctly.